Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Erdoğan blocks Nato accession talks with Sweden and Finland
    • Sunak warns of ‘tough’ few months as UK inflation hits 40-year high
    • Turkey’s Erdoğan plays hardball over Nordics’ Nato bid
    • Gerhard Schröder to be stripped of German parliamentary privileges
    • China diverts anti-poverty funds to Covid testing as crisis deepens
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • US stocks suffer worst day since early months of pandemic
    • JPMorgan shareholders vote against Jamie Dimon’s pay
    • US rushes to catch up with China in supercomputer race
    • Why don’t computers work?
    • Janet Yellen targets Russian oil in EU talks with price cap and tariff proposals
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • KPMG’s Carillion case should worry juniors across the City
    • The mauling of Tiger Global
    • JPMorgan shareholders vote against Jamie Dimon’s pay
    • UK pubs forced to cut discounts and limit menus as costs soar
    • Boeing found a new headquarters. But customers fear it has ‘lost its way’
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • US stocks suffer worst day since early months of pandemic
    • Live news updates from May 18: US stocks suffer worst day since 2020, Turkey forces Nato to postpone Nordic membership talks
    • UK regulators struggle to recruit staff for post-Brexit roles
    • Investors pull $7bn from Tether as stablecoin jitters intensify
    • The dollar’s rapid rise increases risks for global economy
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • KPMG’s Carillion case should worry juniors across the City
    • Why buying a flat might not be such a good idea
    • Boris Johnson must embrace the Brexit he made
    • A Brexit opportunity worth grasping
    • Beating inflation will require more than rate rises
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • As a longtime trailing spouse, how do I get back into full-time work?
    • Spreadsheets are now cool, thanks to TikTok
    • Are universities suffering from management bloat?
    • “Oleg, it’s obviously great news that you have not been sanctioned”
    • Bonuses are outdated in the age of knowledge work
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Why buying a flat might not be such a good idea
    • Robert Armstrong is cast away in Colombia
    • How do today’s musicians make money?
    • Balenciaga’s trashed trainers tap into fashion controversy
    • Iced coffee – condensed
  • How to Spend It
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • How to Spend It
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Coronavirus treatment

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Tuesday, 17 May, 2022
    Covid-19 vaccines
    African leaders urge global vaccine body to buy locally made Covid jabs

    Plea comes as continent’s top vaccine production plant faces uncertain future due to collapse in demand

  • Thursday, 12 May, 2022
    Coronavirus pandemic
    US to share Covid vaccine technology with poorer nations, says Biden

    The president announced the move at a virtual summit hosted by the US, Belize, Germany, Indonesia and Senegal

  • Tuesday, 10 May, 2022
    Coronavirus pandemic
    WHO chief warns that China’s zero-Covid strategy is not sustainable

    New modelling underscores country’s vulnerability because of faltering vaccination drive

  • Monday, 9 May, 2022
    Covid-19 vaccines
    BioNTech beats forecasts on back of Covid vaccine demand

    German biotech maintains guidance but prepares for fall in sales because of jab oversupply

  • Thursday, 5 May, 2022
    Coronavirus pandemic
    ‘Stay vigilant’: no let-up in North Korea’s two-year Covid lockout

    Pyongyang claims to have avoided a big outbreak but experts warn its luck will eventually run out

  • Wednesday, 4 May, 2022
    Moderna
    Moderna targets autumn release for Omicron vaccine

    US drugmaker says demand for ‘bivalent booster’ could lift jab sales in second half of 2022

  • Wednesday, 4 May, 2022
    UK accused of leaving Covid immunocompromised ‘out to dry’

    Vulnerable people feel they are forgotten because of government’s ‘living with Covid’ strategy

  • Sunday, 1 May, 2022
    Coronavirus pandemic
    Africa’s top Covid vaccine plant faces uncertain future after production halted

    The problems threaten plans to produce 60 per cent of all vaccines administered in Africa locally by 2040

  • Friday, 29 April, 2022
    AstraZeneca PLC
    AstraZeneca sales beat forecasts on Covid jab demand

    Revenue rises 60% as Alexion acquisition and its rare diseases medicines boost drugmaker’s earnings

  • Wednesday, 27 April, 2022
    Moderna
    Moderna investors reject proposal to transfer vaccine tech

    Two top-10 shareholders say distribution problems not supply is reason for slower vaccination rates in low-income countries

  • Wednesday, 27 April, 2022
    GlaxoSmithKline PLC
    GSK beats forecasts on back of Covid and shingles treatments

    UK drugmaker points to ‘good momentum’ as sales rise by a third in ‘landmark year’

  • Tuesday, 26 April, 2022
    Coronavirus pandemic
    China’s Covid booster campaign slows as staff redirected to mass testing

    Almost 20mn Beijing residents will have to undergo 3 rounds of tests by Saturday

  • Tuesday, 26 April, 2022
    Special ReportFT Health: Innovation in Healthcare
    Pandemic bolsters EU’s role in health policy

    ‘There has been a change in attitudes. There are a lot of initiatives that were not foreseen a couple of years ago’

  • Monday, 25 April, 2022
    Lex
    Roche/diagnostics: Covid vaccine victory means test makers take a rest Premium content

    Do not dismiss the possibility of another upturn in the coronavirus testing market

  • Monday, 25 April, 2022
    Roche Holding AG
    Roche sales boosted by North American demand for Covid tests

    Swiss pharmaceuticals group expects revenue from coronavirus treatments will decline this year

  • Saturday, 23 April, 2022
    ‘Test to treat’ chaos is latest setback for US Covid pandemic response

    Biden’s flagship scheme giving antiviral pills to at-risk patients has run into multiple problems

  • Friday, 22 April, 2022
    The Top LineTom Braithwaite
    ‘We are drowning in vaccine.’ What will revive the market for Covid jabs?

    Moderna’s chief says there is ‘massive oversupply’

  • Friday, 22 April, 2022
    The FT ViewThe editorial board
    China counts the cost of its zero-Covid policy

    Beijing ought to swallow its pride and approve foreign mRNA vaccines

  • Thursday, 21 April, 2022
    WHO urges Pfizer to make Covid antiviral drug pricing more transparent

    Global body fears that lack of clarity may mean poorer countries lack access to Paxlovid

  • Thursday, 21 April, 2022
    The FT ViewThe editorial board
    Ensuring a healthy Covid legacy for poorer nations

    Other diseases kill more than coronavirus in the global south

  • Wednesday, 20 April, 2022
    Novavax publishes positive initial data for first combined Covid and flu vaccine

    Early clinical findings show that two-in-one shot could be safe and effective

  • Wednesday, 20 April, 2022
    Oxford BioMedica PLC
    Oxford BioMedica warns revenue will be hit by AstraZeneca jab uncertainty

    Shares slide as London-listed group announces ‘pause’ in vaccine manufacturing

  • Wednesday, 20 April, 2022
    News in-depthChinese politics & policy
    Scientists urge China to replace its faltering Covid vaccines

    Omicron outbreak in Shanghai has refocused attention on waning efficacy of homegrown jabs

  • Tuesday, 19 April, 2022
    Covid-19 vaccines
    Moderna and Pfizer urged to share vaccine technology with developing world

    Proxy advisers back shareholder resolutions as new shot shows promising results

  • Tuesday, 19 April, 2022
    Pharmaceuticals sector
    Cambridge start-up searches for next Covid jab in animal faeces

    University spinout is developing two vaccines to help prevent future pandemics

Previous page You are on page 1 Next page

Recommended

Covid-19 vaccines
Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
Covid-19 vaccines
Covid vaccine development: The shots available and the doses administered
Covid-19 vaccines
In graphics: the UK vaccine supply chain
Coronavirus: free to read
Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • How to Spend It
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In